Rowan
Clinically-aware AI documentation, built to support clinicians
Why Rowan Exists
Why Rowan Exists
Why Rowan Exists
Modern AI tools can generate clinical notes quickly and fluently. But when a complaint, audit, or inquest occurs, it isn’t the software that carries the risk — it’s the doctor. Rowan is being developed by clinicians and AI engineers to support documentation that stands up to real-world medico-legal scrutiny — not just speed.
What Rowan focuses on
What Rowan focuses on
What Rowan focuses on
Medico-legal defensibility in everyday clinical notes
Documentation quality in high-risk settings including aged care, mental health, and emergency presentations
Supporting Australian GPs and IMGs working under real pressure Rowan provides structured feedback on documentation quality to help clinicians identify areas that may warrant further consideration before notes are finalised.
Medico-legal defensibility in everyday clinical notes
Documentation quality in high-risk settings including aged care, mental health, and emergency presentations
Supporting Australian GPs and IMGs working under real pressure Rowan provides structured feedback on documentation quality to help clinicians identify areas that may warrant further consideration before notes are finalised.
Medico-legal defensibility in everyday clinical notes
Documentation quality in high-risk settings including aged care, mental health, and emergency presentations
Supporting Australian GPs and IMGs working under real pressure Rowan provides structured feedback on documentation quality to help clinicians identify areas that may warrant further consideration before notes are finalised.
Current Status
Current Status
Current Status
Rowan is entering controlled pilot use, concentrating on documentation quality, consent, and clinical governance. The focus is on building carefully, validating assumptions, and prioritising clinician safety over speed of release. Developed with close attention to Australian regulatory guidance and clinical governance principles.
Rowan is entering controlled pilot use, concentrating on documentation quality, consent, and clinical governance. The focus is on building carefully, validating assumptions, and prioritising clinician safety over speed of release. Developed with close attention to Australian regulatory guidance and clinical governance principles.
Rowan is entering controlled pilot use, concentrating on documentation quality, consent, and clinical governance. The focus is on building carefully, validating assumptions, and prioritising clinician safety over speed of release. Developed with close attention to Australian regulatory guidance and clinical governance principles.
Early Access
Early Access
Early Access
If you’re a clinician interested in following Rowan’s development, being considered for early access, or providing feedback, you’re welcome to register your interest below.
If you’re a clinician interested in following Rowan’s development, being considered for early access, or providing feedback, you’re welcome to register your interest below.
If you’re a clinician interested in following Rowan’s development, being considered for early access, or providing feedback, you’re welcome to register your interest below.